Explanation: This chart demonstrates the dose–response relationship for shockwave therapy on muscle recovery. The x-axis shows energy delivered per session in kilojoules, ranging from 10 to 100, while the y-axis shows a Recovery Index from 0 to 100 that reflects functional improvement measured after treatment cycles. The data points indicate a general positive trend: as the dose increases, the recovery index tends to rise, suggesting higher energy per session can accelerate healing and strength gains when used within a safe window. The line’s shape reveals that gains are most pronounced in the middle range (approximately 40–80 kJ), where successive increases yield notable improvements. At very low doses, improvements are modest, while at the highest doses increments begin to taper, hinting at diminishing returns and the importance of avoiding unnecessary exposure. Individual variability is evident: some patients achieve substantial recovery at moderate doses, whereas others require higher doses to reach comparable levels. These observations underscore the value of personalized dosing strategies, balanced against safety, patient tolerance, and cost considerations. For manufacturers and clinicians, the implication is to establish a standardized, evidence-based dose range that reliably produces meaningful gains while staying within device capabilities and safety guidelines. The dataset also highlights the role of treatment planning, including session frequency, recovery-target timelines, and the integration of rehabilitation exercises that reinforce gains from energy delivery. While this visualization provides a compact view of a dose–response pattern, it remains a simplification; real-world outcomes depend on multiple interacting factors such as baseline muscle condition, age, comorbidities, nutrition, and adherence. Future work should leverage larger, randomized cohorts and longer follow-up to confirm durability, identify subgroup differences, and refine dosing recommendations. This chart can serve as a benchmark for broader adoption, enabling comparison across devices and protocols. Overall, the data support informed decision-making toward a consistent, patient-centered standard in shockwave therapy for muscle recovery.